Net Cash Provided by (Used in) Financing Activities of CANNAPHARMARX, INC. from 31 Mar 2010 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
CANNAPHARMARX, INC. quarterly and annual Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 31 Mar 2010 to 31 Mar 2025.
  • CANNAPHARMARX, INC. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $600,433, a 7.2% increase year-over-year.
  • CANNAPHARMARX, INC. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $1,698,738, a 28% decline from 2023.
  • CANNAPHARMARX, INC. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $2,353,419, a 68% increase from 2022.
  • CANNAPHARMARX, INC. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $1,404,703, a 4.8% increase from 2021.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

CANNAPHARMARX, INC. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $600,433 +$40,161 +7.2% 01 Jan 2025 31 Mar 2025 10-Q 16 May 2025 2025 Q1
Q1 2024 $560,272 +$66,963 +14% 01 Jan 2024 31 Mar 2024 10-Q 16 May 2025 2025 Q1
Q1 2023 $493,309 -$22,956 -4.4% 01 Jan 2023 31 Mar 2023 10-Q 25 Jun 2024 2024 Q1
Q1 2022 $516,265 +$19,542 +3.9% 01 Jan 2022 31 Mar 2022 10-Q 22 Sep 2023 2023 Q1
Q1 2021 $496,723 +$153,723 +45% 01 Jan 2021 31 Mar 2021 10-Q 23 May 2022 2022 Q1
Q1 2020 $343,000 +$263,955 +334% 01 Jan 2020 31 Mar 2020 10-Q 17 May 2021 2021 Q1
Q1 2019 $79,045 +$79,045 01 Jan 2019 31 Mar 2019 10-Q 29 Jun 2020 2020 Q1
Q1 2018 $0 $0 01 Jan 2018 31 Mar 2018 10-Q 15 May 2019 2019 Q1
Q1 2017 $0 -$19,758 -100% 01 Jan 2017 31 Mar 2017 10-Q 14 Sep 2018 2018 Q1
Q1 2016 $19,758 -$434,743 -96% 01 Jan 2016 31 Mar 2016 10-Q 14 Sep 2018 2017 Q1
Q1 2015 $454,501 +$448,454 +7416% 01 Jan 2015 31 Mar 2015 10-Q 14 Sep 2018 2016 Q1
Q1 2014 $6,047 +$647 +12% 01 Jan 2014 31 Mar 2014 10-Q 19 May 2014 2014 Q1
Q1 2013 $5,400 -$200 -3.6% 01 Jan 2013 31 Mar 2013 10-Q 19 May 2014 2014 Q1
Q1 2012 $5,600 -$9,400 -63% 01 Jan 2012 31 Mar 2012 10-Q 10 May 2013 2013 Q1
Q1 2011 $15,000 $0 0% 01 Jan 2011 31 Mar 2011 10-Q 01 Jul 2011 2011 Q1
Q1 2010 $15,000 01 Jan 2010 31 Mar 2010 10-Q 01 Jul 2011 2011 Q1

CANNAPHARMARX, INC. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $1,698,738 -$654,681 -28% 01 Jan 2024 31 Dec 2024 10-K 10 Apr 2025 2024 FY
2023 $2,353,419 +$948,716 +68% 01 Jan 2023 31 Dec 2023 10-K 10 Apr 2025 2024 FY
2022 $1,404,703 +$64,224 +4.8% 01 Jan 2022 31 Dec 2022 10-K 01 Sep 2023 2022 FY
2021 $1,340,479 +$515,906 +63% 01 Jan 2021 31 Dec 2021 10-K 01 Sep 2023 2022 FY
2020 $824,573 -$2,441,872 -75% 01 Jan 2020 31 Dec 2020 10-K 15 Apr 2022 2021 FY
2019 $3,266,445 +$1,134,445 +53% 01 Jan 2019 31 Dec 2019 10-K 14 Apr 2021 2020 FY
2018 $2,132,000 +$2,132,000 01 Jan 2018 31 Dec 2018 10-K 27 May 2020 2019 FY
2017 $0 -$19,758 -100% 01 Jan 2017 31 Dec 2017 10-K 03 Apr 2019 2018 FY
2016 $19,758 -$790,713 -98% 01 Jan 2016 31 Dec 2016 10-K 14 Sep 2018 2017 FY
2015 $810,471 -$2,486,595 -75% 01 Jan 2015 31 Dec 2015 10-K 14 Sep 2018 2016 FY
2014 $3,297,066 01 Jan 2014 31 Dec 2014 10-K 11 Sep 2018 2015 FY
2012 $10,913 -$1,116 -9.3% 01 Jan 2012 31 Dec 2012 10-K 28 Mar 2013 2012 FY
2011 $12,029 -$47,971 -80% 01 Jan 2011 31 Dec 2011 10-K 28 Mar 2013 2012 FY
2010 $60,000 01 Jan 2010 31 Dec 2010 10-K/A 30 Jun 2011 2010 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.